Bilateral Seminal Vesicle Invasion as a Strong Prognostic Indicator in T3b Prostate Cancer Patients Following Radical Prostatectomy: A Comprehensive, Multi-Center, Long-Term Follow-Up Study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Pathologic T3b (pT3b) prostate cancer, characterized by seminal vesicle invasion (SVI), exhibits variable oncological outcomes post–radical prostatectomy (RP). Identifying prognostic factors is crucial for patient-specific management. This study investigates the impact of bilateral SVI on prognosis in pT3b prostate cancer. Materials and Methods We evaluated the medical records of a multi-institutional cohort of men who underwent RP for prostate cancer with SVI between 2000 and 2012. Univariate and multivariable analyses were performed using Kaplan-Meier analysis and covariate-adjusted Cox proportional hazard regression for biochemical recurrence (BCR), clinical progression (CP), and cancer-specific survival (CSS). Results Among 770 men who underwent RP without neo-adjuvant treatment, median follow-up was 85.7 months. Patients with bilateral SVI had higher preoperative prostate-specific antigen levels and clinical T category (all p < 0.001). Extracapsular extension, tumor volume, lymph node metastasis (p < 0.001), pathologic Gleason grade group (p < 0.001), and resection margin positivity (p < 0.001) were also higher in patients with bilateral SVI. The 5-, 10-, and 15-year BCR-free survival rates were 23.9%, 11.7%, and 8.5%; CP-free survival rates were 82.8%, 62.5%, and 33.4%; and CSS rates were 96.4%, 88.1%, and 69.5%, respectively. The bilateral SVI group demonstrated significantly lower BCR-free survival rates, CP-free survival rates, and CSS rates (all p < 0.001). Bilateral SVI was independently associated with BCR (hazard ratio, 1.197; 95% confidence interval, p=0.049), CP (p=0.022), and CSS (p=0.038) in covariate-adjusted Cox regression. Conclusion Bilateral SVI is a robust, independent prognostic factor for poor oncological outcomes in pT3b prostate cancer.
Abstract
Purpose Pathologic T3b (pT3b) prostate cancer, characterized by seminal vesicle invasion (SVI), exhibits variable oncological outcomes post–radical prostatectomy (RP). Identifying prognostic factors is crucial for patient-specific management. This study investigates the impact of bilateral SVI on prognosis in pT3b prostate cancer. Materials and Methods We evaluated the medical records of a multi-institutional cohort of men who underwent RP for prostate cancer with SVI between 2000 and 2012. Univariate and multivariable analyses were performed using Kaplan-Meier analysis and covariate-adjusted Cox proportional hazard regression for biochemical recurrence (BCR), clinical progression (CP), and cancer-specific survival (CSS). Results Among 770 men who underwent RP without neo-adjuvant treatment, median follow-up was 85.7 months. Patients with bilateral SVI had higher preoperative prostate-specific antigen levels and clinical T category (all p < 0.001). Extracapsular extension, tumor volume, lymph node metastasis (p < 0.001), pathologic Gleason grade group (p < 0.001), and resection margin positivity (p < 0.001) were also higher in patients with bilateral SVI. The 5-, 10-, and 15-year BCR-free survival rates were 23.9%, 11.7%, and 8.5%; CP-free survival rates were 82.8%, 62.5%, and 33.4%; and CSS rates were 96.4%, 88.1%, and 69.5%, respectively. The bilateral SVI group demonstrated significantly lower BCR-free survival rates, CP-free survival rates, and CSS rates (all p < 0.001). Bilateral SVI was independently associated with BCR (hazard ratio, 1.197; 95% confidence interval, p=0.049), CP (p=0.022), and CSS (p=0.038) in covariate-adjusted Cox regression. Conclusion Bilateral SVI is a robust, independent prognostic factor for poor oncological outcomes in pT3b prostate cancer.
참고문헌 (29)
- Culp MB, "Recent global patterns in prostate cancer incidence and mortality rates", Eur Urol, 77, pp.38~52 (2020)
- Buhmeida A, "Prognostic factors in prostate cancer", Diagn Pathol, 1, pp.4~ (2006)
- Mukamel E, "The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate", Cancer, 59, pp.1535~1538 (1987)
- Goupy F, "Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement(T3b) : a multicentric retrospective analysis", PLoS One, 14, pp.e0210514~ (2019)
- Pierorazio PM, "A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion(pT3b)after radical prostatectomy", J Urol, 185, pp.1691~1697 (2011)
- Mikel Hubanks J, "The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes", Urol Oncol, 32, pp.26~ (2014)
- Secin FP, "Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy", Cancer, 106, pp.2369~2375 (2006)
- Epstein JI, "Adenocarcinoma of the prostate invading the seminal vesicle : prognostic stratification based on pathologic parameters", Urology, 56, pp.283~288 (2000)
- Mottet N, "EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1 : screening, diagnosis, and local treatment with curative intent", Eur Urol, 79, pp.243~262 (2021)
- Tilki D, "Adjuvant versus early salvage radiation therapy for men at high risk for recurrence following radical prostatectomy for prostate cancer and the risk of death", J Clin Oncol, 39, pp.2284~2293 (2021)
- Parker C, "Prostate cancer : ESMO clinical practice guidelines for diagnosis, treatment and follow-up", Ann Oncol, 31, pp.1119~1134 (2020)
- Lee HJ, "Does bilateral seminal vesicle invasion at radical prostatectomy predict worse prognosis than unilateral invasion among patients with pT3b prostate cancers?", Int J Urol, 23, pp.758~763 (2016)
- Kristiansen A, "Prognostic significance of patterns of seminal vesicle invasion in prostate cancer", Histopathology, 62, pp.1049~1056 (2013)
- Vidal Crespo N, "Bilateral seminal vesicle invasion is not associated with worse outcomes in locally advanced prostate carcinoma", Medicina(Kaunas), 58, pp.1057~ (2022)
- Numbere N, "The clinical impact of unilateral versus bilateral invasion into the seminal vesicle in patients with prostate cancer undergoing radical prostatectomy", Arch Pathol Lab Med, 146, pp.855~861 (2022)
- Epstein JI, "A contemporary prostate cancer grading system : a validated alternative to the Gleason score", Eur Urol, 69, pp.428~435 (2016)
- Buyyounouski MK, "Prostate cancer : major changes in the American Joint Committee on Cancer eighth edition cancer staging manual", CA Cancer J Clin, 67, pp.245~253 (2017)
- Cookson MS, "Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer : the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes", J Urol, 177, pp.540~545 (2007)
- Boorjian SA, "Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy : the impact of time from surgery to recurrence", Eur Urol, 59, pp.893~899 (2011)
- Jain B, "Prostate cancer disparities in risk group at presentation and access to treatment for Asian Americans, native Hawaiians, and Pacific islanders : a study with disaggregated ethnic groups", JCO Oncol Pract, 18, pp.e204~e218 (2022)
- Zhu Y, "Epidemiology and genomics of prostate cancer in Asian men", Nat Rev Urol, 18, pp.282~301 (2021)
- Sachdeva A, "Positive surgical margins and biochemical recurrence following minimally-invasive radical prostatectomy : an analysis of outcomes from a UK tertiary referral centre", BMC Urol, 17, pp.91~ (2017)
- Pagano MJ, "Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy", Prostate, 76, pp.226~234 (2016)
- Maxeiner A, "Significant reduction in positive surgical margin rate after laparoscopic radical prostatectomy by application of the modified surgical margin recommendations of the 2009 International Society of Urological Pathology consensus", BJU Int, 118, pp.750~757 (2016)
- Fleshner NE, "Clinical significance of the positive surgical margin based upon location, grade, and stage", Urol Oncol, 28, pp.197~204 (2010)
- Zhang L, "Surgical margin status and its impact on prostate cancer prognosis after radical prostatectomy : a meta-analysis", World J Urol, 36, pp.1803~1815 (2018)
- Retel VP, "Determinants and effects of positive surgical margins after prostatectomy on prostate cancer mortality : a population-based study", BMC Urol, 14, pp.86~ (2014)
- Jemal A, "Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations", JAMA, 314, pp.2054~2061 (2015)
- Egevad L, "International Society of Urological Pathology(ISUP)consensus conference on handling and staging of radical prostatectomy specimens : rationale and organization", Mod Pathol, 24, pp.1~5 (2011)